Massimo Mannelli

CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2001)

A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients

Gian Paolo Rossi;Giampaolo Bernini;Chiara Caliumi;Giovambattista Desideri.
Journal of the American College of Cardiology (2006)

Biochemical diagnosis of pheochromocytoma: which test is best?

Jacques W. M. Lenders;Karel Pacak;McClellan M. Walther;W. Marston Linehan.
JAMA (2002)

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Cell (2018)

Adjuvant mitotane treatment for adrenocortical carcinoma.

Massimo Terzolo;Alberto Angeli;Martin Fassnacht;Fulvia Daffara.
The New England Journal of Medicine (2007)

Pheochromocytoma: recommendations for clinical practice from the First International Symposium

Karel Pacak;Graeme Eisenhofer;Håkan Ahlman;Stefan R Bornstein.
Nature Clinical Practice Endocrinology & Metabolism (2007)

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

Francien H van Nederveen;José Gaal;Judith Favier;Esther Korpershoek.
Lancet Oncology (2009)

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)

Integrated genomic characterization of adrenocortical carcinoma

Guillaume Assié;Eric Letouzé;Martin Fassnacht;Anne Jouinot.
Nature Genetics (2014)

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

Iñaki Comino-Méndez;Francisco J Gracia-Aznárez;Francesca Schiavi;Iñigo Landa.
Nature Genetics (2011)